Aldose reductase and the role of the polyol pathway in diabetic nephropathy

Kidney International, Supplement

Volumn 58, Issue 77, 2000, Pages

  Dunlop, M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aldose reductase; Carbonyl stress; Diabetes mellitus; Oxidative stress; Polyol pathway; Transgenesis

Indexed keywords

ALDEHYDE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; POLYOL; PROSTAGLANDIN; PROTEIN KINASE C; DIACYLGLYCEROL; FREE RADICAL; POLYMER;

ANIMAL TISSUE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; HYPERGLYCEMIA; KIDNEY TUBULE; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION; ANIMAL; BIOSYNTHESIS; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; PHYSIOLOGY; RAT;

ALDEHYDE REDUCTASE; ANIMALS; DIABETIC NEPHROPATHIES; DIGLYCERIDES; FREE RADICALS; GLUCOSE; GLYCOSYLATION; HUMANS; KIDNEY TUBULES; OXIDATIVE STRESS; POLYMERS; RATS;

EID: 0033857113     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07702.x     Document Type: Review

References (95)

1. Effect of intensive therapy on the development and progression of diabetic nephropathy in the DCCT
2. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and the risk of complication in patients with type 2 diabetes
3. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
4. Pathogenesis, prevention, and treatment of diabetic nephropathy
5. The link between hyperglycemia and diabetic nephropathy
6. Aldose reductase expression is increased in diabetic nephropathy
7. Reduction of glomerular hyperfiltration in normoalbuminaemic IDDM patients by 6 mo of aldose reductase inhibition
8. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy
9. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy
10. Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: Effect on urinary albumin excretion
11. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys
12. Renal proximal and distal tubular function is attenuated in diabetes mellitus type I as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein
13. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
14. Immunohistochemical localization of aldose reductase. II Rat eye kidney
15. Localization of aldose and aldehyde reductase in the kidney
16. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells
17. +ATPase activity in acute and chronic diabetes and with aldose reductase inhibition
18. Hypertonicity-induced accumulation of organic osmolytes in papillary interstitial cells
19. Coordinate regulation of organic osmolytes in renal cells
20. Mechanism of development and possible prevention of sugar cataracts
21. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats
22. 3-deoxyglucosone: Metabolism, analysis, biological activity, and clinical implication
23. +
24. Hyperglycemic pseudohypoxia and diabetic complications
25. Control of glyceraldehyde-3-phosphate dehydrogenase in cardiac muscle
26. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts
27. Renal hypertrophy in experimental diabetes. Changes in pentose phosphate pathway activity
28. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels
29. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia
30. 2 activation
31. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes
32. Glycation products and the pathogenesis of diabetic complications
33. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription
34. Advanced glycation end products in serum predicts changes in the kidney morphology of patients with insulin-dependent diabetes mellitus
35. Amadori albumin in type 1 diabetic patients. Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in renal capillaries
36. Retardation by aminogyanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats
37. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
38. Autoxidative glycosylation and possible involvment of peroxides and free radicals in LDL modification by glucose
39. Role of oxidative stress in diabetic complications; a new perspective on an old paradigm
40. Carbonyl stress in the pathogenesis of diabetic nephropathy
41. Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase
42. N-ε-(Carboxyethyl) lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
43. Biology of disease. Free radicals and tissue injury
44. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH
45. Reactive oxygen species as glomerular autocoids
46. Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney
47. Involvement of reactive oxygen species in kidney damage
48. Inhibition of cytotoxicity by intracellular superoxide dismutase
49. Nε-(Carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
50. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions
51. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions
52. Substrate specificity of aldose reductase: Identification of 4-hydroxynonenal as an endogenous substrate
53. Major differences exist in the function and tissue specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members
54. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes
55. Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney
56. Signal for induction of aldose reductase in renal medullary cells by high external NaCl
57. Effects of osmotic stress and hyperglycemia on aldose reductase gene expression in human renal proximal tubule cells
58. Induction of aldose reductase expression in rat kidney mesangial cells and Chinese hamster ovary cells under hypotonic conditions
59. Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells
60. Aldose reductase mRNA expression and its activity are induced by glucose in fetal rat aortic smooth muscle (A10) cells
61. The induction of aldose reductase activity and its mRNA expression by glucose in fetal rat aortic smooth muscle (A7r5) cells
62. Regulation of aldose reductase gene-expression in renal-cortex and medulla of rats
63. Feedback inhibition of aldose reductase gene expression in rat renal medulla
64. Effects of galactose feeding on aldose reductase expression
65. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozotocin-induced diabetic rats
66. Effect of insulin and statil on aldose reductase expression in diabetic rats
67. ORE, a eukaryotic minimal essential osmotic response element. The aldose reductase gene in hyperosmotic stress
68. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene
69. Isolation of the mouse aldose reductase promoter and identification of a tonicity-responsive element
70. Characterization of the aldose-reductase-encoding gene family in rat
71. Aldose reductase: A window to the treatment of diabetic complications?
72. Induction of rat aldose reductase gene transcription is mediated through the cis-element, osmotic response element (ORE): Increased synthesis and/or activation by phosphorylation of ORE-binding protein is a key step
73. 4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase
74. Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase
75. Signal transduction in rat vascular smooth muscle cells: Control of osmotically induced aldose reductase expression by cell kinases and phosphatases
76. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C
77. Effect of glucose on stress activated protein kinase activity in mesangial cells and diabetic glomeruli
78. Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in experimental diabetes and oxidative stress
79. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA
80. Galactose-induced albuminuria in transgenic mice expressing human aldose reductase
81. Demonstration that polyol accumulation is responsible for diabetic cataract by use of transgenic mice expressing the aldose reductase gene in the lens
82. Contributions of polyol pathway to oxidative stress in diabetic cataract
83. Cytoskeletal dissociation of ezrin during renal anoxia: Role of microvillar injury
84. Effects of integrins on proliferation and apoptosis of renal epithelial cells after acute injury
85. Lipid peroxidation in isolated rat nephron segments
86. Strategic locus for activation of the superoxide dismutase gene in the nephron
87. Ischemic damage and repair in the rat proximal tubule: Differences among the S1, S2 and S3 segments
88. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat
89. 4-hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: Protein modification and redox alteration
90. Metabolic rates of 4-hydroxynonenal in tubular and mesangial cells of the kidney
91. Role of lipid aldehydes in cataractogenesis: 4-hydroxynonenal-induced cataract
92. Aldose reductase induction: A novel response to oxidative stress of smooth muscle cells
93. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-nonenal, in isolated perfused rat heart
94. Reduction of 4-hydroxynonenela and 4-hydroxyhexanal by retinal aldose reductase
95. Aldose reductase functions as a detoxification system for lipid peroxidation in vasculitis